Andrew J. Lawrence – författare

Effects of Pollution on Fish brings together the work of many international experts each of whom have examined the literature on marine and freshwater fish and, where appropriate, invertebrates, to produce comprehensive chapters covering all major aspects of the impacts of pollution on fish and fisheries. The book describes these impacts in detail, from the molecular and sub-cellular level, through organism to population and community levels, and subsequently to socio-economic implications.

The editors of this thorough and timely book have drawn together contributions encompassing molecular genetics, biochemistry, physiology, population and community biology, and fishery economics. As such, this important book will be of great use and interest to students and professionals studying and teaching in all those subject areas. Fish biologists, environmental scientists and ecotoxicologists, marine and freshwater ecologists, fisheries managers, aquaculture personnel and fish farmers, as well as fish veterinarians will all find much of great value within this book. Libraries in universities and research establishments concerned with these areas should all have copies of this book on their shelves.

This issue of Current Topics in Behavioral Neuroscience focuses on the neuropeptide orexin (hypocretin) and brings together scientists from around the world who will provide a timely discussion of how this peptide regulates behavior. This is a fast-moving field, and with the incorporation of novel technologies, new breakthroughs are likely to continue. For example, the use of optogenetic approaches has enabled the identification of the role of orexin-containing neurons in arousal states, critical for higher order functioning. From a clinical perspective, genetic polymorphisms in hypocretin/orexin and orexin receptors are implicated in a number of psychiatric disorders. In addition, advanced clinical trials are currently underway for orexin receptor antagonists in the treatment of insomnia and sleep disorders. We aim to capture a broad audience of basic scientists and clinicians.